Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.50% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
BGLC · Dec 31, 2025
BioNexus Gene Lab Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001477932-26-002218General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-24.76% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.shares_outstanding
-86.55% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
-21.93% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
9.11% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
14.62% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-39.93% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.68% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
10.70% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History29 statesSelf-history eligible
Sep 30, 20214/6 normalizedLevel 3Dec 31, 20214/6 normalizedLevel 3Mar 31, 20225/6 normalizedLevel 3Jun 30, 20225/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20226/6 normalizedLevel 3Mar 31, 20236/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/6 normalizedAmended as filedDec 31, 20236/6 normalizedLevel 3Mar 31, 20245/5 normalizedLevel 3Jun 30, 20245/5 normalizedLevel 3Sep 30, 20245/5 normalizedLevel 3Dec 31, 20246/8 normalizedLevel 3Mar 31, 20256/7 normalizedLevel 3Jun 30, 20256/7 normalizedLevel 3Sep 30, 20256/7 normalizedLevel 3Dec 31, 20256/9 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.22%
- Current
- 0.50%
- Delta
- 0.28%
- Previous
- -48.65%
- Current
- -24.76%
- Delta
- 23.89%
- Previous
- -3.29%
- Current
- -21.93%
- Delta
- -18.64%
- Previous
- 39.60%
- Current
- 9.11%
- Delta
- -30.49%
- Previous
- 14.85%
- Current
- 14.62%
- Delta
- -0.23%
- Previous
- -27.62%
- Current
- -39.93%
- Delta
- -12.32%
- Previous
- 0.58%
- Current
- 0.68%
- Delta
- 0.10%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · BGLC Fundamental State →Transitioned To · BGLC Fundamental State →Transitioned To · BGLC CAPEX_INTENSITY_INCREASED →Transitioned To · BGLC CASH_GENERATION_INCREASED →Transitioned To · BGLC GROWTH_DECREASED →Transitioned To · BGLC INVENTORY_PRESSURE_DECREASED →Transitioned To · BGLC MARGIN_DECREASED →Transitioned To · BGLC PROFITABILITY_DECREASED →Transitioned To · BGLC R_AND_D_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.